MAPT and Alzheimer disease: Abnormal tau, characterized by hyperphosphorylated tau and its inclusion in NFTs as the second prominent indication of neuropathology in AD, has been reported in retinal layers, particularly the plexiform layer, inner nuclear layer, and ganglion cell layer of post-mortem retinas of confirmed AD cases [19–21].